Company / Working Capital
ALX ONCOLOGY HOLDINGS INC Working Capital History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$242.6M
FY2022
5-year range
$242.6M / $429.8M
FY2020-FY2022
Trend
-31.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $430M to $243M over the past 2 years.
Based on SEC 10-K filings.
$243M in FY2022.
Declined from $430M to $243M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, working capital decreased 31.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $242.6M | -31.0% |
| FY2021 | $351.7M | -18.2% |
| FY2020 | $429.8M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026